Slides on Key Decisions in HIV Care: Considering Tenofovir Alafenamide in Pregnancy

Learn the latest data about whether to use tenofovir alafenamide during pregnancy.
person default
Milena Murray, PharmD, MSc, BCIDP, AAHIVP
Format: Microsoft PowerPoint (.ppt)
File Size: 351 KB
Released: September 24, 2021

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Related Content

Concise Clinical Care Options (CCO) presentation by Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: October 15, 2021 Expired: October 14, 2022

Clinical Care Options (CCO) slides from Nicholas Chamberlain, MD, on investigational HIV PrEP strategies in various stages of development

Nicholas Chamberlain, MD Released: October 15, 2021

Perspective on continuation of BIC/FTC/TAF in suppressed patients who become pregnant, from Clinical Care Options (CCO) and Dr. William R. Short

William R. Short, MD, MPH, AAHIVS Released: October 15, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue